
John Lin, MD, MSHP
Department of Health Services Research, Division of Cancer Prevention and Population Sciences
Present Title & Affiliation
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
2022 | University of Pennsylvania, Philadelphia, Pennsylvania, US, Health Policy, MSHP |
2014 | Baylor College of Medicine, Houston, Texas, US, MD |
2008 | Harvard College, Cambridge, Massachusetts, US, Economics, AB |
Postgraduate Training
2019-2022 | Clinical Fellowship, Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania |
2017-2019 | Research Fellowship, Health Services Research, VA Palo Alto and Stanford University, Palo Alto, California |
2015-2017 | Clinical Residency, Internal Medicine, University of California, San Francisco, San Francisco, California |
2014-2015 | Clinical Internship, Internal Medicine, University of California, San Francisco, San Francisco, California |
Board Certifications
2022 | Medical Oncology |
2018 | Internal Medicine |
Honors & Awards
2025 | 40 Under 40 In Cancer: Rising Stars and Emerging Leaders, AVBCC |
2022 | Young Investigator Award, ASCO Conquer Cancer |
2022 | Rising STARs Award, University of Texas |
2019 | Editor’s Pick for Original Article, Journal of Clinical Oncology |
2016 | Outstanding Resident Research Award, UCSF |
2013 | Alpha Omega Alpha, Baylor College of Medicine |
2011 | U.S. Albert Schweitzer Fellowship, Houston-Galveston |
2008 | Carl and Lily Pforzheimer Public Service Fellowship, Harvard College |
2008 | Magna Cum Laude, Harvard College |
2007 | Cordeiro Health Policy Fellowship, Harvard College |
2005 | John Harvard Scholar, Harvard College |
2005 | Detur Prize, Harvard College |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Doshi JA, Li P, Klebanoff MJ, Lin JK. Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs. JAMA Health Forum 6(5), 2025. e-Pub 2025. PMID: 40377932.
- Doshi JA, Li P, Asthana S, Lin JK. Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan. JCO Oncol Pract, 2025. e-Pub 2025. PMID: 40279533.
- Xiang JJ, Campbell MT, Tu SM, Araujo J, Nieto Y, Lin JK, Xiao L, Shah AY, Wang J. Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors. Clin Genitourin Cancer 22(6):102242, 2024. e-Pub 2024. PMID: 39532049.
- Klebanoff MJ, Li P, Lin JK, Doshi JA. Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans. JAMA, 2024. e-Pub 2024. PMID: 38842823.
- Sinharoy A, Reddy N, Lin JK, Nambi V, Yang EY, Kougias P, Taylor AA, Lumsden AB, Ballantyne CM, Brunner G. Longitudinal Magnetic Resonance Imaging-Based Superficial Femoral Artery Velocity Measurements in Diabetic and Nondiabetic Patients With Peripheral Artery Disease. Top Magn Reson Imaging 32(6):57-65, 2023. e-Pub 2023. PMID: 38051028.
- Sinharoy A, Reddy N, Lin JK, Nambi V, Yang EY, Kougias P, Taylor AA, Lumsden AB, Ballantyne CM, Morrisett JD, Brunner G. Magnetic resonance imaging based superficial femoral artery velocity measurements in peripheral artery disease. Magn Reson Imaging 93:128-134, 2022. e-Pub 2022. PMID: 35940380.
- Lin JK, Jacobs LA, Blauch A, Shulman LN, Vaughn DJ. Guideline discordant care in patients with metastatic germ cell tumors. Urol Oncol 40(8):385.e9-385.e17, 2022. e-Pub 2022. PMID: 35659482.
- Lin JK, Li P, Doshi JA, Desai SM. Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics. JAMA Health Forum 3(6):e221435, 2022. e-Pub 2022. PMID: 35977245.
- Sandhu AT, Heidenreich PA, Lin JK, Parizo J, Bhattacharya J, Goldhaber-Fiebert JD. Perks and Pitfalls of Performance-Linked Reimbursement for Novel Drugs: The Case of Sacubitril-Valsartan. Circ Cardiovasc Qual Outcomes 15(1):e007993, 2022. e-Pub 2022. PMID: 35041480.
- Barnes JI, Lin JK, Gupta D, Owens DK, Goldhaber-Fiebert JD, Kunz PL. Cost-Effectiveness of Initial Versus Delayed Lanreotide for Treatment of Metastatic Enteropancreatic Neuroendocrine Tumors. J Natl Compr Canc Netw 18(9):1200-1209, 2020. e-Pub 2020. PMID: 32886901.
- Lin JK, Hong J, Phibbs C, Almenoff P, Wagner T. Evaluating the Role of Past Clinical Information on Risk Adjustment. Med Care 58(2):169-173, 2020. e-Pub 2020. PMID: 31688567.
- Bentham J, Singh GM, Danaei G, Green R, Lin JK, Stevens GA, Farzadfar F, Bennett JE, Cesare MD, Dangour AD, Ezzati M. Multi-dimensional characterisation of global food supply from 1961-2013. Nat Food 1(1):70-75, 2020. e-Pub 2020. PMID: 32002520.
- Lin JK, Moran AE, Bibbins-Domingo K, Falase B, Pedroza Tobias A, Mandke CN, Kazi DS. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study. Lancet Glob Health 7(10):e1346-e1358, 2019. e-Pub 2019. PMID: 31477544.
- Lin JK, Muffly LS, Spinner MA, Barnes JI, Owens DK, Goldhaber-Fiebert JD. Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma. J Clin Oncol 37(24):2105-2119, 2019. e-Pub 2019. PMID: 31157579.
- Lin JK, Lerman BJ, Barnes JI, Boursiquot BC, Tan YJ, Robinson AQL, Davis KL, Owens DK, Goldhaber-Fiebert JD. Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia. J Clin Oncol 36(32):3192-3202, 2018. e-Pub 2018. PMID: 30212291.
- Raffel KE, Beach LY, Lin JK, Berchuck JE, Abram S, Markle E, Patel S. Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care Clinic. Perm J 22, 2018. e-Pub 2018. PMID: 29616917.
- Lin JK, Chow DS, Sheu L, Rehani B. Wernicke-Like Encephalopathy Associated With Ifosfamide. Neurohospitalist 7(1):49-50, 2017. e-Pub 2017. PMID: 28042371.
- (NCD-RisC) NCD. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol 3(8):624-37, 2015. e-Pub 2015. PMID: 26109024.
- Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M. Response to letter regarding article, "the global cardiovascular risk transition: associations of four metabolic risk factors with macroeconomic variables in 1980 and 2008". Circulation 128(18):e378, 2013. e-Pub 2013. PMID: 24166421.
- Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, Dellavalle R, Danaei G, Ezzati M, Fahimi A, Flaxman D, Foreman, Gabriel S, Gakidou E, Kassebaum N, Khatibzadeh S, Lim S, Lipshultz SE, London S, Lopez, MacIntyre MF, Mokdad AH, Moran A, Moran AE, Mozaffarian D, Murphy T, Naghavi M, Pope C, Roberts T, Salomon J, Schwebel DC, Shahraz S, Sleet DA, Murray, Abraham J, Ali MK, Atkinson C, Bartels DH, Bhalla K, Birbeck G, Burstein R, Chen H, Criqui MH, Dahodwala, Jarlais, Ding EL, Dorsey ER, Ebel BE, Ezzati M, Fahami, Flaxman S, Flaxman AD, Gonzalez-Medina D, Grant B, Hagan H, Hoffman H, Kassebaum N, Khatibzadeh S, Leasher JL, Lin JK, Lipshultz SE, Lozano R, Lu Y, Mallinger L, McDermott MM, Micha R, Miller TR, Mokdad AA, Mokdad AH, Mozaffarian D, Naghavi M, Narayan KM, Omer SB, Pelizzari PM, Phillips D, Ranganathan D, Rivara FP, Roberts T, Sampson U, Sanman E, Sapkota A, Schwebel DC, Sharaz S, Shivakoti R, Singh GM, Singh D, Tavakkoli M, Towbin JA, Wilkinson JD, Zabetian A, Murray, Abraham J, Ali MK, Alvardo M, Atkinson C, Baddour LM, Benjamin EJ, Bhalla K, Birbeck G, Bolliger I, Burstein R, Carnahan E, Chou D, Chugh SS, Cohen A, Colson KE, Cooper LT, Couser W, Criqui MH, Dabhadkar KC, Dellavalle RP, Jarlais, Dicker D, Dorsey ER, Duber H, Ebel BE, Engell RE, Ezzati M, Felson DT, Finucane MM, Flaxman S, Flaxman AD, Fleming T, Foreman, Freedman G, Freeman MK, Gakidou E, Gillum RF, Gonzalez-Medina D, Gosselin R, Gutierrez HR, Hagan H, Havmoeller R, Hoffman H, Jacobsen KH, James SL, Jasrasaria R, Jayarman S, Johns N, Kassebaum N, Khatibzadeh S, Lan Q, Leasher JL, Lim S, Lipshultz SE, London S, Lopez, Lozano R, Lu Y, Mallinger L, Meltzer M, Mensah GA, Michaud C, Miller TR, Mock C, Moffitt TE, Mokdad AA, Mokdad AH, Moran A, Naghavi M, Narayan KM, Nelson RG, Olives C, Omer SB, Ortblad K, Ostro B, Pelizzari PM, Phillips D, Raju M, Razavi H, Ritz B, Roberts T, Sacco RL, Salomon J, Sampson U, Schwebel DC, Shahraz S, Shibuya K, Silberberg D, Sing. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310(6):591-608, 2013. e-Pub 2013. PMID: 23842577.
- Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M, Collaborating Group GBOMRFOCD. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation 127(14):1493-502, 1502e1-8, 2013. e-Pub 2013. PMID: 23481623.
- Collaboration GBD. GBD 2010 country results: a global public good. Lancet 381(9871):965-70, 2013. e-Pub 2013. PMID: 23668561.
- Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Lin, JK. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163-96, 2012. e-Pub 2012. PMID: 23245607.
- Lim, Vos T, Murray CJ, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Lin JK, Knowlton LM, Kobusingye O, Koranteng A. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2197-223, 2012. e-Pub 2012. PMID: 23245608.
- Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Mohd Hanafiah K, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner LJ, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224-60, 2012. e-Pub 2012. PMID: 23245609.
- Singh GM, Danaei G, Pelizzari PM, Lin JK, Cowan MJ, Stevens GA, Farzadfar F, Khang YH, Lu Y, Riley LM, Lim SS, Ezzati M. The age associations of blood pressure, cholesterol, and glucose: analysis of health examination surveys from international populations. Circulation 125(18):2204-2211, 2012. e-Pub 2012. PMID: 22492580.
- G* D, MM* F, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM, Ezzati M, co-first author) GBOMRFOCDCG(P(. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet 377(9765):568-77, 2011. e-Pub 2011. PMID: 21295844.
- Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, Mass Index) GBOMRFOCDCG(. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 377(9765):557-67, 2011. e-Pub 2011. PMID: 21295846.
- Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM, Ezzati M, Group (Cholesterol) GBOMRFOCDC. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants. Lancet 377(9765):578-86, 2011. e-Pub 2011. PMID: 21295847.
Other Articles
- LS* G, Lin JK, Lage DE, Kessler ER, Parikh RB, co-first author) MA( Management of Prostate Cancer in Older Adults. Am Soc Clin Oncol Educ Book 43:e390396, 2023. PMID: 37207299.
- Diseases Collaboration GBOMRFFC Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2(8):634-47, 2014. PMID: 24842598.
- Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, (Blood Glucose) GBOMRFOCDCG National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378(9785):31-40, 2011. PMID: 21705069.
Editorials
- Bange EM, Lin JK. Time Toxicity of Clinical Trials-Better Than Feared. JAMA Netw Open 8(4), 2025. PMID: 40232726.
- Lin JK, Barnes JI, Doshi JA, Ghabri S, Kolominsky-Rabas P, O’Rourke B. The Medicare Drug Price Negotiation Program: Arriving at a Fair Price - Considerations from Other Countries. Health Affairs Forefront, 2023.
- Lin JK, Barnes JI, Doshi JA. The Medicare Drug Price Negotiation Program: Considerations For Therapeutic Alternatives. Health Affairs Forefront, 2023.
Selected Presentations & Talks
Local Presentations
- 2024. Disparities in Oncology. Invited. PACE Education Series. Houston, Texas, US.
- 2024. Case Discussions Testicular Cancer. Invited. 2nd Annual Christopher G. Wood Advances In Urologic Oncology. Houston, Texas, US.
- 2024. Economics of Cancer Drugs & Impact of Cancer Drug Shortages. Invited. The UCLA Seminar on Pharmaceutical Economics and Policy (2024-2025). Houston, Texas, US.
- 2023. Addressing Health Care Disparities in GU Cancers. Invited. UT Christopher G. Wood Advances In Urologic Oncology. Houston, Texas, US.
- 2022. Disparities in Novel Anticancer Therapies. Conference. Disparities in Novel Anticancer Therapies. Houston, TX, US.
National Presentations
- 2022. Pharmacy Contracting with 340B Providers from 2006-2019: Growth by Neighborhood Socioeconomic Characteristics. Conference. Pharmacy Contracting with 340B Providers from 2006-2019: Growth by Neighborhood Socioeconomic Characteristics. Austin, TX, US.
- 2022. Cost-effectiveness of chimeric antigen receptor T-cell therapy in triple-class refractory multiple myeloma. Conference. Cost-effectiveness of chimeric antigen receptor T-cell therapy in triple-class refractory multiple myeloma, US.
- 2021. Financial Stewardship In an Era of Hematologic Advances in Care: Whose Value? What Price?: CAR-T. Conference. Financial Stewardship In an Era of Hematologic Advances in Care: Whose Value? What Price?: CAR-T. Atlanta, GA, US.
- 2019. New Models for Risk Adjustment. Conference. New Models for Risk Adjustment, US.
- 2016. Cost-Effectiveness of a Fixed-Dose Combination Pill for Secondary Prevention of Cardiovascular Disease in China, India, Mexico, Ghana, and South Africa. Conference. Cost-Effectiveness of a Fixed-Dose Combination Pill for Secondary Prevention of Cardiovascular Disease in China, India, Mexico, Ghana, and South Africa. New Orleans, LA, US.
International Presentations
- 2020. An Independent Evaluation of the Economic Value of the Two Approved CAR-T Cells. Conference. An Independent Evaluation of the Economic Value of the Two Approved CAR-T Cells. Madrid, ES.
- 2019. Are CAR-T Cells and Novel Cellular Therapies Cost-Effective?. Conference. Are CAR-T Cells and Novel Cellular Therapies Cost-Effective?. New York, US.
- 2018. Calibrating Models of Cancer Treatment to Overall and Progression-Free Survival Curves: Consistently Reflecting Uncertainty and Heterogeneity. Conference. Calibrating Models of Cancer Treatment to Overall and Progression-Free Survival Curves: Consistently Reflecting Uncertainty and Heterogeneity. Leiden, NL.
Grant & Contract Support
Date: | 2025 - 2026 |
Title: | Facilitators and Barriers to Cancer Treatment Among Texas Medicare Beneficiaries |
Funding Source: | IRG |
Role: | PI |
Date: | 2024 - 2029 |
Title: | Impact of the 340B Drug Pricing Program on Medication Utilization, Health Outcomes, and Disparities in Medicare |
Funding Source: | NIH |
Role: | PI |
ID: | 1R01AG086300-01A1 |
Date: | 2024 - 2025 |
Title: | Equity in Hepatocellular Carcinoma Treatment and Outcomes in Medicare Advantage versus Traditional Medicare |
Funding Source: | CPRIT |
Role: | PI |
ID: | RP210130 |
Date: | 2024 - 2026 |
Title: | The Impact of Insurance Policies on Racial and Ethnic Disparities in Access to Prostate Cancer Second Generation Androgen Receptor Pathway Inhibitors |
Funding Source: | Prostate Cancer Foundation |
Role: | PI |
Date: | 2024 - 2026 |
Title: | Maximizing Efficacy and Minimizing Toxicity of Immune Checkpoint Therapies (ICTs) in Diverse Subgroups of Patients with Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | P20 CA290238-01 |
Date: | 2024 - 2029 |
Title: | Impact of the 340B Drug Pricing Program on Medication Utilization, Health Outcomes, and Disparities in Medicare |
Funding Source: | NIH |
Role: | PI |
ID: | FP00019234_Res1 |
Date: | 2024 - 2029 |
Title: | Cancer Care, Outcomes, and Health Equity in Medicare Advantage versus Traditional Medicare |
Funding Source: | American Cancer Society (ACS) |
Role: | PI |
Date: | 2024 - 2029 |
Title: | The impacts of the 340B Drug Pricing Program on medication use, adherence, and outcomes |
Funding Source: | NIH/NCI |
Role: | Co-I |
Date: | 2023 - 2028 |
Title: | Optimizing prostate cancer treatment for people living with HIV |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | CA285342 |
Date: | 2023 - 2023 |
Title: | Medicare Drug Price Negotiation Under the Inflation Reduction Act: Defining Therapeutic Alternatives and Assessing Therapeutic Advances |
Funding Source: | The Commonwealth Fund |
Role: | PI |
Date: | 2022 - 2025 |
Title: | UT System Rising STARs Award |
Funding Source: | The University of Texas System |
Role: | PI |
Date: | 2022 - 2023 |
Title: | Young Investigator Award |
Funding Source: | American Society of Clinical Oncology (ASCO) |
Role: | PI |
ID: | 14762 |
Date: | 2022 - 2022 |
Title: | Pilot Grant |
Funding Source: | Leonard Davis Institute |
Role: | PI |
Date: | 2021 - 2021 |
Title: | Geographic Management of Cancer Health Disparities Region 4 Research Stimulus Award |
Funding Source: | NIH/NCI |
Role: | PI |
Date: | 2020 - 2022 |
Title: | Ruth L. Kirchstein National Research Service Award: Postdoctoral Training In Health Services Research |
Funding Source: | Agency for Healthcare Research and Quality |
Role: | Trainee |
ID: | 5-T32-HS-026116-01 |
Date: | 2015 - 2016 |
Title: | CTSI Resident Research Funding Award |
Funding Source: | University of California, San Francisco |
Role: | PI |
Patient Reviews
CV information above last modified May 29, 2025